Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $12.8000 (-2.85%) ($12.7400 - $12.8000) on Thu. Mar. 18, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.79% (three month average) | RSI | 66 | Latest Price | $12.8000(-2.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.2% a day on average for past five trading days. | Weekly Trend | BCRX advances 6.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(40%) IWO(37%) IWC(35%) IWM(35%) | Factors Impacting BCRX price | BCRX will decline at least -3.395% in a week (0% probabilities). VIXM(-20%) UUP(-15%) VXX(-7%) IGOV(-6%) TBT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.395% (StdDev 6.79%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $13.03(-1.77%) | 10 Day Moving Average | $12.64(1.27%) | 20 Day Moving Average | $12.01(6.58%) | To recent high | -6.1% | To recent low | 81.7% | Market Cap | $2.258b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |